Medicinal Chemistry (Biopharmaceutical Products)

Medicinal Chemistry (Biopharmaceutical Products) Companies (20)

Medicinal Chemistry (Biopharmaceutical Products) News

Medicinal Chemistry (Biopharmaceutical Products) Products (25)

  • Product FLUOLEAD

    Innovative nucleophilic fluorination agentBest alternative to DAST, Deoxo-fluor,... Ketone (non-enol form) and carboxylic acid can be fluorinated HIgh thermal stability Easy to handle (solid product) Only 1 step needed for deoxo-fluorination
  • Product Uroquinasa (UROKINASE) SYNER MEDICA 500.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemia
  • Product Microreaction Synthesis Platform

    The MO-FLOW-S microreaction synthesis platform is a general flow chemistry synthesis platform-type equipmentlaunched by Oushisheng Technology based on application requirements. The platform can carry multiple modulesincluding feeding, inline pressure control, microreactor, inline measurement, and inline sa...
  • Product APIs

    • Paclitaxel (Package : Up to 500g Per request) • Pemetrexed (Package : Up to 1kg Per request) • Bortezomib (Package : Up to 40g Per request)
  • Product Synthetic Chemistry

    Recipharm offer a range of synthetic chemistry services through our global development facilities including advanced lead optimisation medicinal chemistry, process development and tech transfer to large scale GMP-manufacturing and other specialties.
  • Product Invix®

    Invix® is Versalis' new hand and surface disinfectant made using ethanol of vegetable origin as an active ingredient.This product is a Surgical Medical Device authorized by the Ministry of Health*, developed on the formulation of the World Health Organization.

    ...
  • Product Discovery Chemistry Services

    Aurigene Pharmaceutical Services offers a wide range of discovery chemistry services to biotech, pharmaceutical, agrochemical and specialty chemical companies. This includes synthesis of a library of compounds from a few milligrams to multi-hundred gram scale or differentiated solutions for your discovery ...
  • Product Research & Development

    Discovery - Biology, Lead Optimization, Libraries, Synthetic & Medicinal ChemistryDevelopment - Chemical Process R&D, Fermentation, Formulation Development, High Potency, Kilo Lab & Small Scale Manufacturing, Lipid Nanoparticle, Method Development/Material Science, Rare/Orphan, Separation Scien...
  • Product URSA

    25, 50, 100, 200, 250, 300mg - Tab., Soft Cap., Hard Cap.

    UDCA (Ursodeoxycholic Acid)

    Indication:
    Cholestasis(include PBC, PSC), Viral hepatitis C, Gallstone

    URSA improves liver function in chronic hepatitis patients, improves symptom and histopathology in Cholestatis...
  • Product cannabigerol

    Rare cannabinoids:CBC Series/CBG Series/CBD Series(CBC/CBCV/CBG/CBGP/CBDV/CBDB/CBDH/CBDP/CBDC8
  • Product Simon Caplan

    Samedan and PM Group are a Pharmaceutical and Healthcare publishing house. We will be exhibiting the following magazines: 1. European Biopharmaceutical Review(EBR) 2. Pharmaceutical Manufacturer and Packing Sourcer (PMPS) 3. International Clinical Trials (ICT) 4. INnovations in Pharmaceutical Technology(IP...
  • Product Uroquinasa (UROKINASE) SYNER MEDICA 250.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemi...
  • Product Uroquinasa (UROKINASE) SYNER MEDICA 100.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemia
  • Product Drug Substance

    Recipharm has more than 25 years’ experience in drug substance development and manufacturing. We are ideally placed to deliver a wide range of drug substance services from our dedicated development facilities around the world.
  • Product Buidling Blocks

    Over 500K advanced building blocks in stock
  • Product Olostar 20/10mg and 40/20mg - Tab.

    Olmesartan medoxomil, Rosuvastatin

    Indication: Concomitant Hypertension and Dyslipidemia

    <World's 1st fixed dose combination of olmesartan and rosuvastatin>
    1. Developed with Daewoong's patented formulation technology
    2. Indicated for the treatment of both hypertensio...
  • Product Regorafenib

    Its a Oncology API
  • Product Enzalutamide

    Its a Oncology API

Upcoming Events

  • Pharmapack Europe 2025

    Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
    22 Jan 2025 - 23 Jan 2025
  • CPHI Japan 2025

    East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
    09 Apr 2025 – 11 Apr 2025
  • CPHI Americas 2025

    Pennsylvania Convention Center, Philadelphia
    20 May 2025 - 22 May 2025

Pharmaceutical Industry Webinars